Protego Biopharma

About:

Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy.

Website: https://protegobiopharma.com

Top Investors: Lightspeed Venture Partners, Vida Ventures, MPM Capital

Description:

Protego Biopharma develops therapeutics based on the clear human genetic link, excellent human safety profile, proof-of-principle efficacy. The company was founded in 2011 and is headquartered in San Diego, California.

Total Funding Amount:

$51M

Headquarters Location:

San Diego, California, United States

Founded Date:

2011-01-01

Founders:

Richard Labaudinière

Number of Employees:

11-50

Last Funding Date:

2021-10-19

IPO Status:

Private

Industries: